Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
about
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesParaneoplastic neurological complications of breast cancer.Identification of novel autoantibodies for detection of malignant mesotheliomaImproved approach to identify cancer-associated autoantigens.Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer.Multiple serological biomarkers for colorectal cancer detection.Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokersPreferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigensProtein Array-based Approaches for Biomarker Discovery in Cancer.Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinomaDetection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis.Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.Technical validation of an autoantibody test for lung cancer.Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.Circulating antinuclear antibodies in patients with pelvic masses are associated with malignancy and decreased survivalPreliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.Autoimmunity and tumor immunology: two facets of a probabilistic immune systemClinical validation of an autoantibody test for lung cancer.Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.Development of a multiplex autoantibody test for detection of lung cancerLatest updates on antiretinal autoantibodies associated with vision loss and breast cancer.Anti-centrosome antibodies in breast cancer are the expression of autoimmunity.Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer.Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.Autoimmune response to PARP and BRCA1/BRCA2 in cancerCIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer.Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymomaEarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.Tumor-associated antigen arrays for the serological diagnosis of cancer.Proteomics approaches to urologic diseases.Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinomaAntibody profiling with protein antigen microarrays in early stage cancer.
P2860
Q26999045-0A607428-9509-432E-A264-FA5267E5107FQ28077708-AC0705A3-AE89-4B80-881B-75B11387C6FDQ28387447-27D04B33-F7FB-45F1-8F0C-21F386EBA422Q33215080-DDDBF35E-FC50-4853-A6B3-299935E8B7BFQ33432974-D978F1CA-EE51-43D3-84BC-A04888CA241DQ33507935-FE7253DE-3554-45CF-B7F6-C550403D8AF7Q33588113-F53C9233-A5F2-4C47-940B-3876AB91A1AAQ33594076-4CB211DE-FD68-4D18-9A46-4D19B12B5F8BQ33632268-8099F475-BE5D-4320-A300-227D7189AB8AQ33719973-9A8F4E83-2834-425C-ACD4-9D3D58892F82Q33890172-F0DBDC78-4336-489F-81E6-FD050485DE31Q33895858-3B3E562B-9293-432B-A448-7D2A1E6A9D5DQ33895872-8D5E89FA-C6FD-425D-9515-4EA93ECDD321Q33946598-BE0B301F-66DD-4A7E-892B-43A8A4A3C61AQ33967422-950D42DF-E80E-45C6-9C76-A508C9B9F742Q34024944-4897E835-E540-4F98-9510-DC8DFC8FC2DCQ34049184-07D6EAE2-4FFD-4D56-BB04-3EE46B2A1B66Q34138916-E9D74A97-2EF2-428C-A84D-493F55971DECQ34170421-3CEEB57E-EACA-4CA5-9B36-F4A99BC63C36Q34276070-41A2FB92-1991-4A57-92BB-AA65226EB131Q34309299-87DD1539-0BC5-4155-8C12-6E5D30E79E4FQ34537272-BEB86F87-8696-45AF-9075-2141048E1979Q34537374-8CD0B9AD-23F7-4EBE-BBC6-6DD7C15D7A56Q35059164-4E71C4BA-E0B5-4F4C-BB92-08B49103A989Q35089751-32056367-F93E-4D00-8C97-010C51C54102Q35154906-5ABE5964-79F7-4FB2-AFF1-5E94CD5C7582Q35161069-AE244EE4-B564-42CE-955E-F28AB1ACD485Q35446906-BFE3292A-3A04-4627-B533-F4EB69B401BDQ35583352-27ECE57A-CD2F-4867-B723-2319D6DC5ADAQ35607101-75908E3C-DA1E-450F-8DA0-62BB97956219Q35632045-42B3037A-96F1-4ECA-8A0E-118746FDBA62Q35793861-18CE7245-E335-4241-9496-D9B3A22D706BQ35839042-16200D47-CF8B-4808-AD98-680A0C2C6A35Q36214596-A9835E93-43C9-4844-A1F1-D1DB4848F44CQ36285345-15EFB997-5BBE-4EEC-A19C-9791A3864FD3Q36491988-618655C5-2979-4AA5-8162-04CCDA6F9B93Q36505667-EC36B4EC-28D9-4BA4-AB15-78DFCD082228Q36605447-D61C2FE5-0C4E-4D4C-A76F-170262D6D61CQ36640435-ED4D4B83-5E67-4C47-AAD9-0F1242CDE843Q36682206-EE01FCD4-6545-4453-A495-1D8C5A7333FB
P2860
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
@ast
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
@en
type
label
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
@ast
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
@en
prefLabel
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
@ast
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
@en
P2860
P356
P1476
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
@en
P2093
P2860
P304
P356
10.1172/JCI14451
P407
P577
2001-11-01T00:00:00Z